NPC is characterized by the infiltration of lymphocytes and positive programmed death-ligand 1 (PD-L1) expression in tumor cells, which makes it an attractive target for immune checkpoint inhibitors (ICIs). Here, CD274 is linked to nasopharyngeal carcinoma.